Cocrystal Pharma, Inc. is a clinical-stage biotechnology company based in Bothell, WA, specializing in the discovery and development of novel antiviral therapeutics. With a focus on targeting the replication process of various viruses, including SARS-CoV-2, influenza, norovirus, and hepatitis C, the company utilizes a unique structure-based drug discovery technology platform and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. Driven by the global need for effective and safe antiviral treatments, Cocrystal Pharma is advancing multiple antiviral therapeutic candidates as quickly and efficiently as possible. Their development programs encompass a wide range of serious and chronic viral diseases, including influenza, COVID-19, hepatitis C, and gastroenteritis caused by norovirus. Through their targeted solutions for viral diseases, the company aims to combat the ongoing pandemic and seasonal influenza, as well as address other high-value indications.Generated from the website